Peter Lwabi

Peter Lwabi

Auto-generated profile, based on publicly available information

Peter Lwabi

Uganda Heart Institute, Kampala, Uganda

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 November 2014 in European Heart Journal
Verified
Journal Article
Open access
PDF file
LZLiesl Zühlke
Liesl Zühlke
MEMark Emmanuel Engel
Mark Emmanuel Engel
GKGanesan Karthikeyan
Ganesan Karthikeyan
SRSumathy Rangarajan
Sumathy Rangarajan
PMPam Mackie
Pam Mackie
BMBongani M. Mayosi
Bongani M. Mayosi
Rheumatic heart disease (RHD) accounts for over a million premature deaths annually; however, there is little contemporary information on presentation, complications, and treatment. This prospective registry enrolled 3343 patients (median age 28 years, 66.2% female) presenting with RHD at 25 hospitals in 12 African countries, India, and Yemen between January 2010 and November 2012. The majority (63.9%) had moderate-to-severe multivalvular disease complicated by congestive heart failure (33.4%), pulmonary hypertension (28.8%), atrial fibrillation (AF) (21.8%), stroke (7.1%), infective endocarditis (4%), and major bleeding (2.7%). One-quarter of adults and 5.3% of children had decreased left ventricular (LV) systolic function; 23% of adults and 14.1% of children had dilated LVs. Fifty-five percent (n = 1761) of patients were on secondary antibiotic prophylaxis. Oral anti-coagulants were prescribed in 69.5% (n = 946) of patients with mechanical valves (n = 501), AF (n = 397), and high-risk mitral stenosis in sinus rhythm (n = 48). However, only 28.3% (n = 269) had a therapeutic international normalized ratio. Among 1825 women of childbearing age (12–51 years), only 3.6% (n = 65) were on contraception. The utilization of valvuloplasty and valve surgery was higher in upper-middle compared with lower-income countries. Rheumatic heart disease patients were young, predominantly female, and had high prevalence of major cardiovascular complications. There is suboptimal utilization of secondary antibiotic prophylaxis, oral anti-coagulation, and contraception, and variations in the use of percutaneous and surgical interventions by country income level.

26 June 2012 in Circulation
Verified
Journal Article
Open access
PDF file
ABAndrea Beaton
Andrea Beaton
EOEmmy Okello
Emmy Okello
PLPeter Lwabi
Peter Lwabi
CMCharles Mondo
Charles Mondo
RMRobert McCarter
Robert McCarter
CSCraig Sable
Craig Sable
Background—: Historically, sub-Saharan Africa has had the highest prevalence rates of clinically detected rheumatic heart disease (RHD). Echocardiography-based screening improves detection of RHD in endemic regions. The newest screening guidelines (2006 World Health Organization/National Institutes of Health) have been tested across India and the Pacific Islands, but application in sub-Saharan Africa has, thus far, been limited to Mozambique. We used these guidelines to determine RHD prevalence in a large cohort of Ugandan school children, to identify risk factors for occult disease, and to assess the value of laboratory testing. Methods and Results—: Auscultation and portable echocardiography were used to screen randomly selected schoolchildren, 5 to 16 years of age, in Kampala, Uganda. Disease likelihood was defined as definite, probable, or possible in accordance with the 2006 National Institutes of Health/World Health Organization guidelines. Ninety-seven percent of eligible students received screening (4869 of 5006). Among them, 130 children (2.7%) had abnormal screening echocardiograms. Of those 130, secondary evaluation showed 72 (55.4%) with possible, probable, or definite RHD; 18 (13.8%) with congenital heart disease; and 40 (30.8%) with no disease. Echocardiography detected 3 times as many cases of RHD as auscultation: 72 (1.5%) versus 23 (0.5%; P <0.001). Children with RHD were older (10.1 versus 9.3 years; P =0.002). Most cases (98%) involved only the mitral valve. Lower socioeconomic groups had more RHD (2.7% versus 1.4%; P =0.036) and more advanced disease (64% versus 26%; P <0.001). Antistreptolysin O titers were elevated in children with definite RHD. Conclusions—: This is one of the largest single-country childhood RHD prevalence studies and the first to be conducted in sub-Saharan Africa. Our data support inclusion of echocardiography in screening protocols, even in the most resource-constrained settings, and identify lower socioeconomic groups as most vulnerable. Longitudinal follow-up of children with echocardiographically diagnosed subclinical RHD is needed.

6 January 2015 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Open access
PDF file
ABAndrea Beaton
Andrea Beaton
JLJimmy C. Lu
Jimmy C. Lu
TATwalib Aliku
Twalib Aliku
PDPeter Dean
Peter Dean
LGLasya Gaur
Lasya Gaur
CSCraig Sable
Craig Sable
The World Heart Federation (WHF) guidelines for rheumatic heart disease (RHD) are designed for a standard portable echocardiography (STAND) machine. A recent study in a tertiary care centre demonstrated that they also had good sensitivity and specificity when modified for use with handheld echocardiography (HAND). Our study aimed to evaluate the performance of HAND for early RHD diagnosis in the setting of a large-scale field screening. STAND was performed in 4773 children in Gulu, Uganda, with 10% randomly assigned to also undergo HAND. Additionally, any child with mitral or aortic regurgitation also underwent HAND. Studies were performed by experienced echocardiographers and blindly reviewed by cardiologists using 2012 WHF criteria, which were modified slightly for HAND—due to the lack of spectral Doppler capability. Paired echocardiograms were performed in 1420 children (mean age 10.8 and 53% female), resulting in 1234 children who were normal, 133 who met criteria for borderline RHD, 47 who met criteria for definite RHD, and 6 who had other diagnoses. HAND had good sensitivity and specificity for RHD detection (78.9 and 87.2%, respectively), but was most sensitive for definite RHD (97.9%). Inter- and intra-reviewer agreement ranged between 66–83 and 71.4–94.1%, respectively. HAND has good sensitivity and specificity for diagnosis of early RHD, performing best for definite RHD. Protocols for RHD detection utilizing HAND will need to include confirmation by STAND to avoid over-diagnosis. Strategies that evaluate simplified screening protocols and training of non-physicians hold promise for more wide spread deployment of HAND-based protocols.

1 January 2014 in Journal of the American Society of Echocardiography
Verified
Journal Article
Closed access
ABAndrea Beaton
Andrea Beaton
TATwalib Aliku
Twalib Aliku
EOEmmy Okello
Emmy Okello
SLSulaiman Lubega
Sulaiman Lubega
RMRobert McCarter
Robert McCarter
CSCraig Sable
Craig Sable

16 May 2013 in CardioVascular Journal of Africa
Verified
Journal Article
Open access
EOEmmy Okello
Emmy Okello
ZWZhang Wanzhu
Zhang Wanzhu
CMCharles Musoke
Charles Musoke
ATAliku Twalib
Aliku Twalib
BKBarbara Kakande
Barbara Kakande
JFJuergen Freers
Juergen Freers
Complications of rheumatic heart disease are associated with severe morbidity and mortality in developing countries where the disease prevalence remains high. Due to lack of screening services, many patients present late, with severe valve disease. In Uganda, the disease and its complications are still not well studied. To profile and describe cardiovascular complications in newly diagnosed rheumatic heart disease patients attending the Mulago National Referral Hospital in Uganda. This was a cross-sectional study where consecutive, newly diagnosed rheumatic heart disease patients were assessed and followed up for complications, such as heart failure, pulmonary hypertension, atrial fibrillation, recurrence of acute rheumatic fever, and stroke. A total of 309 (115 males and 196 females) definite rheumatic heart disease patients aged 15-60 years were enrolled in the study and analysed. Complications occurred in 49% (152/309) of the newly diagnosed rheumatic heart disease cases, with heart failure (46.9%) the most common complication, followed by pulmonary arterial hypertension (32.7%), atrial fibrillation (13.9%), recurrence of acute rheumatic fever (11.4%), infective endocarditis (4.5%) and stroke (1.3%). Atrial fibrillation and acute rheumatic fever were the most common complications associated with heart failure. In this study we found that about 50% of newly diagnosed rheumatic heart disease patients in Uganda presented with complications. Heart failure and pulmonary arterial hypertension were the most commonly observed complications.

1 April 2015 in Journal of the American Society of Echocardiography
Verified
Journal Article
Closed access
JLJimmy C. Lu
Jimmy C. Lu
CSCraig Sable
Craig Sable
GEGregory J. Ensing
Gregory J. Ensing
CWCatherine Webb
Catherine Webb
JSJanet Scheel
Janet Scheel
ABAndrea Beaton
Andrea Beaton